| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 87.441 | 118.322 | 171.073 | 173.430 | 176.204 | 144.961 | 71.916 | 123.230 | 239.414 | 249.901 |
| Total Income - EUR | 87.473 | 118.467 | 176.156 | 185.096 | 181.489 | 146.851 | 72.338 | 123.449 | 239.425 | 250.088 |
| Total Expenses - EUR | 84.951 | 116.272 | 136.043 | 156.591 | 175.829 | 136.195 | 71.120 | 138.056 | 217.147 | 241.874 |
| Gross Profit/Loss - EUR | 2.522 | 2.195 | 40.113 | 28.505 | 5.660 | 10.657 | 1.218 | -14.607 | 22.278 | 8.213 |
| Net Profit/Loss - EUR | 1.452 | 1.383 | 36.741 | 26.654 | 3.873 | 9.314 | 560 | -15.716 | 20.347 | 2.002 |
| Employees | 8 | 7 | 9 | 9 | 10 | 7 | 3 | 6 | 9 | 12 |
Check the financial reports for the company - Volus Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 35.474 | 31.353 | 53.074 | 168.247 | 122.316 | 114.897 | 102.640 | 119.283 | 208.085 | 194.747 |
| Current Assets | 16.211 | 17.023 | 45.711 | 41.974 | 40.806 | 46.347 | 38.850 | 41.591 | 59.886 | 68.549 |
| Inventories | 5.622 | 3.233 | 8.467 | 11.197 | 12.783 | 12.533 | 8.679 | 21.727 | 15.899 | 38.576 |
| Receivables | 5.904 | 8.795 | 22.684 | 13.145 | 12.291 | 4.139 | 20.387 | 5.030 | 24.592 | 16.137 |
| Cash | 4.685 | 4.995 | 14.560 | 17.632 | 15.731 | 29.675 | 9.783 | 14.834 | 19.395 | 13.836 |
| Shareholders Funds | 26.721 | 27.832 | 64.102 | 81.541 | 83.836 | 91.560 | 90.090 | 74.653 | 94.774 | 96.246 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.965 | 20.544 | 34.683 | 128.679 | 79.286 | 69.684 | 51.401 | 86.221 | 173.198 | 167.050 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Volus Medica Srl